One of the causes of
resistance to cancer treatment in children is now beginning to be elucidated.
Acute lymphoblastic leukemia patients with a particular form of the ATF5 gene are at higher risk of having a relapse when treated with E. coli asparaginase, a key
chemo-therapy drug for this type of leukemia.
More info »